Cell therapy weekly: Astellas pauses gene therapy trial for X-linked myotubular myopathy

This week: Astellas Pharma has voluntary paused its ASPIRO gene therapy trial for X-linked myotubular myopathy over a serious adverse event, preliminary results have been reported for Poseida Therapeutics’ CAR-T product candidate in prostate cancer, and Therapeutic Solutions has revealed new data and a patent filing covering the use of JadiCells™ for COPD. The news highlights: Astellas pauses gene therapy trial for X-linked myotubular myopathy ‘Encouraging’ early data reported for autologous CAR-T product in prostate cancer Positive preclinical data reported for the use of JadiCells™ in animal model of COPD   Astellas pauses gene therapy trial for X-linked myotubular myopathy...